Clinical Trial Update: The Expression and Effect of Cyr61 in Urinary Tract Transitional Cell Carcinoma

View source ↗

Summary

This clinical trial update reports on the expression and potential effects of Cyr61 in urinary tract transitional cell carcinoma, reflecting ongoing biomarker r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Carcinoma of the Bladder

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Carcinoma, Transitional Cell | Status: UNKNOWN